Document Detail


1alpha-hydroxycholecalciferol: a promising therapeutic approach for renal osteodystrophy.
MedLine Citation:
PMID:  681163     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effectiveness of 1alpha-hydroxycholecalciferol [1alpha-OH)D3] in healing uremic bone disease was investigated in 10 uremic patients on maintenance dialysis. Seven patients received 1alpha-(OH)D3, 2 microgram/day, for six months, and three patients served as a control group. Bone density was determined from X-rays of the second phalanx of the second digit. The apparent intestinal calcium absorption improved on treatment with 1alpha-(OH)D3, serum calcium levels and bone density significantly increased, and a significant decrease in serum alkaline phosphatase activity was observed. In one patient, reversal of uremic myopathy occurred after 17 days of 1alpha-(OH)D3 therapy.
Authors:
L Gotloib; M Mines; Y Mazur; D Sklan; A L Garmizo; J Jancu; M Israeli; M Malul
Related Documents :
3485113 - Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism...
19330573 - Bone mineral density and sex hormone status in intellectually disabled women on progest...
24669623 - Role of serum-ascites albumin gradient in differential diagnosis of ascites.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Israel journal of medical sciences     Volume:  14     ISSN:  0021-2180     ISO Abbreviation:  Isr. J. Med. Sci.     Publication Date:  1978 Jul 
Date Detail:
Created Date:  1978-10-27     Completed Date:  1978-10-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0013105     Medline TA:  Isr J Med Sci     Country:  ISRAEL    
Other Details:
Languages:  eng     Pagination:  731-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Absorptiometry, Photon
Alkaline Phosphatase / blood
Humans
Hydroxycholecalciferols / therapeutic use*
Hypocalcemia / blood,  drug therapy
Intestines / metabolism
Renal Osteodystrophy / blood,  drug therapy*
Uremia / drug therapy
Chemical
Reg. No./Substance:
0/Hydroxycholecalciferols; EC 3.1.3.1/Alkaline Phosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low levels of serum calcium, phosphorus and plasma 25-hydroxy vitamin D in cirrhosis of the liver.
Next Document:  Effect of an egg-rich diet on plasma lipids and proteins in severely burned patients.